In addition to altered ApoE levels, patients with Alzheimer’s disease have increased ferritin levels in their cerebrospinal fluid (CSF), a marker of brain iron content [50,51,52]. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.